Help - Search - Members - Calendar
Full Version: Anaphylactic Shock
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Anaphylactic Shock
Pages: 1, 2, 3
  1. Anaphylactic-Shock: Sulphan blue: anaphylaxis with heart arrest: case report. (0 replies)
  2. Anaphylactic-Shock: Anaphylaxis in the emergency department: a paediatric perspective (0 replies)
  3. Anaphylactic-Shock: Hypersensitivity to antineoplastic agents. (0 replies)
  4. Anaphylactic-Shock: Hypersensitivity reactions to anticoagulant drugs. (0 replies)
  5. Anaphylactic-Shock: Cross-reactive reactions to nonsteroidal anti-inflammatory drugs. (0 replies)
  6. Anaphylactic-Shock: Hypersensitivity reactions to neuromuscular blocking agents. (0 replies)
  7. Anaphylactic-Shock: Anaphylaxis in the emergency department: a paediatric perspective (0 replies)
  8. Anaphylactic-Shock: Effects of early endotoxemia and dextran-induced anaphylaxis on the size-selectivity of the glomerular filtration barrier in rats. (0 replies)
  9. Anaphylactic-Shock: Anaphylaxis hospitalizations on rise among people younger than 20 (0 replies)
  10. Anaphylactic-Shock: A small amount of tetrachloroethylene ingestion from drinking water accelerates antigen-stimulated allergic responses. (0 replies)
  11. Anaphylactic-Shock: [protein structure and folding] crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis (0 replies)
  12. Anaphylactic-Shock: Targeting il-4/il-13 signaling to alleviate oral allergen-induced diarrhea. (0 replies)
  13. Anaphylactic-Shock: Soybean (glycine max) allergy in europe: gly m 5 (beta-conglycinin) and gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy. (0 replies)
  14. Anaphylactic-Shock: Phase i study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a pediatric oncology group study (pog 9376) (0 replies)
  15. Anaphylactic-Shock: Genetic inversion in mast cell-deficient wsh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. (0 replies)
  16. Anaphylactic-Shock: Idiopathic anaphylaxis successfully treated with omalizumab (0 replies)
  17. Anaphylactic-Shock: Anaphylaxis caused by tangerine seeds but not tangerine fruit (0 replies)
  18. Anaphylactic-Shock: The etiology and incidence of anaphylaxis in rochester, minnesota: a report from the rochester epidemiology project. (0 replies)
  19. Anaphylactic-Shock: Cefoperazone/sulbactam: anaphylaxis: case report (0 replies)
  20. Anaphylactic-Shock: Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis. (0 replies)
  21. Anaphylactic-Shock: Anaphylaxis due to methylprednisolone. (0 replies)
  22. Anaphylactic-Shock: Allergen-sensitization increases mast-cell expression of the exocytotic proteins snap-23 and syntaxin 4, which are involved in histamine secretion. (0 replies)
  23. Anaphylactic-Shock: Study of hypersensitivity reactions and anaphylaxis during anesthesia in spain. (0 replies)
  24. Anaphylactic-Shock: Cefoperazone/sulbactam: anaphylaxis: case report. (0 replies)
  25. Anaphylactic-Shock: Wasp sting: an unusual fatal outcome. (0 replies)
  26. Anaphylactic-Shock: Anti-inflammatory activity of pectolinarigenin and pectolinarin isolated from cirsium chanroenicum. (0 replies)
  27. Anaphylactic-Shock: Bovine serum albumin contained in culture medium used in artificial insemination is an important anaphylaxis risk factor (0 replies)
  28. Anaphylactic-Shock: Development and validation of a self-administered food allergy quality of life questionnaire for children (0 replies)
  29. Anaphylactic-Shock: Resuscitation skills for radiologists: a short paper (0 replies)
  30. Anaphylactic-Shock: A practical approach to paediatric emergencies in the radiology department (0 replies)
  31. Anaphylactic-Shock: Increased production of cysteinyl leukotrienes and prostaglandin d2 during human anaphylaxis (0 replies)
  32. Anaphylactic-Shock: [mechanisms of signal transduction] attenuation of ige affinity for fc{epsilon}ri radically reduces the allergic response in vitro and in vivo (0 replies)
  33. Anaphylactic-Shock: Prevesical hydatid cyst: an exceptional occurrence (0 replies)
  34. Anaphylactic-Shock: Epinephrine has been confirmed as the drug of choice for anaphylaxis (0 replies)
  35. Anaphylactic-Shock: [case reports] anaphylaxis following single component measles and rubella immunisation (0 replies)
  36. Anaphylactic-Shock: Immediate anaphylactic death following antibiotics injection: splenic eosinophilia easily revealed by pagoda red stain. (0 replies)
  37. Anaphylactic-Shock: Epinephrine has been confirmed as the drug of choice for anaphylaxis. (0 replies)
  38. Anaphylactic-Shock: Home treatment with elapraseŽ and naglazymeŽ is safe in patients with mucopolysaccharidoses types ii and vi, respectively (0 replies)
  39. Anaphylactic-Shock: Primary care live annual conference and exhibition (excel, london) (0 replies)
  40. Anaphylactic-Shock: Anaphylaxis: educational programs are needed. (0 replies)
  41. Anaphylactic-Shock: Management and successful desensitization in methotrexate-induced anaphylaxis (0 replies)
  42. Anaphylactic-Shock: Amoxicillin/clavulanic acid: anaphylaxis, complicated by stent thrombosis: case report (0 replies)
  43. Anaphylactic-Shock: Bacitracin: anaphylaxis: case report (0 replies)
  44. Anaphylactic-Shock: Cinnamon: anaphylaxis: case report (0 replies)
  45. Anaphylactic-Shock: Inulin: iga nephropathy (first report) and anaphylaxis in a child: case report (0 replies)
  46. Anaphylactic-Shock: What are the most common food allergies? (0 replies)
  47. Anaphylactic-Shock: Amoxicillin/clavulanic acid: anaphylaxis, complicated by stent thrombosis: case report. (0 replies)
  48. Anaphylactic-Shock: Bacitracin: anaphylaxis: case report. (0 replies)
  49. Anaphylactic-Shock: Cinnamon: anaphylaxis: case report. (0 replies)
  50. Anaphylactic-Shock: Inulin: iga nephropathy (first report) and anaphylaxis in a child: case report. (0 replies)
  51. Anaphylactic-Shock: Anaphylaxis after hpv vaccination 'rare' (0 replies)
  52. Anaphylactic-Shock: Anaphylaxis (0 replies)
  53. Anaphylactic-Shock: Maize food allergy: a double-blind placebo-controlled study (0 replies)
  54. Anaphylactic-Shock: Hpv jab has higher anaphylaxis risk (0 replies)
  55. Anaphylactic-Shock: Anaphylactic shock to penicillin. (0 replies)
  56. Anaphylactic-Shock: Anaphylactic shock with coronary stenting thrombosis induced by amoxicillin-clavulanic acid. (0 replies)
  57. Anaphylactic-Shock: Herbex-kid inhibits immediate hypersensitivity reactions in mice and rats (0 replies)
  58. Anaphylactic-Shock: Epidemiology of anaphylaxis. (0 replies)
  59. Anaphylactic-Shock: Rate of anaphylaxis after hpv vaccine higher than other vaccines, australians report (0 replies)
  60. Anaphylactic-Shock: Hpv vaccine linked to high rate of anaphylaxis (0 replies)
  61. Anaphylactic-Shock: Hpv vaccine deemed safe despite higher anaphylaxis rates (0 replies)
  62. Anaphylactic-Shock: Should children with a history of anaphylaxis to foods undergo challenge testing? (0 replies)
  63. Anaphylactic-Shock: Anaphylaxis increases after hpv shot (0 replies)
  64. Anaphylactic-Shock: Cmaj study reveals higher anaphylaxis rates after hpv vaccination (0 replies)
  65. Anaphylactic-Shock: Higher anaphylaxis rates after hpv vaccination (0 replies)
  66. Anaphylactic-Shock: Hpv vaccine shows higher rate of anaphylaxis: study (0 replies)
  67. Anaphylactic-Shock: Anaphylaxis, beta blockade and the kounis syndrome. (0 replies)
  68. Anaphylactic-Shock: Hypersensitivity to inulin: a rare and mostly benign event (0 replies)
  69. Anaphylactic-Shock: Systemic administration of an fcgamma-fc(epsilon)-fusion protein in house dust mite sensitive nonhuman primates. (0 replies)
  70. Anaphylactic-Shock: Allergy and the cardiovascular system. (0 replies)
  71. Anaphylactic-Shock: Higher anaphylaxis rates after hpv vaccination: cmaj study (0 replies)
  72. Anaphylactic-Shock: Diagnosing hypersensitivity reactions to cephalosporins in children (0 replies)
  73. Anaphylactic-Shock: Anaphylaxis following quadrivalent human papillomavirus vaccination. (0 replies)
  74. Anaphylactic-Shock: The human papillomavirus vaccine and risk of anaphylaxis. (0 replies)
  75. Anaphylactic-Shock: Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione (0 replies)
  76. Anaphylactic-Shock: Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice (0 replies)
  77. Anaphylactic-Shock: Nut allergies foremost in pediatric anaphylaxis (0 replies)
  78. Anaphylactic-Shock: Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice. (0 replies)
  79. Anaphylactic-Shock: Review paper food-dependent exercise-induced anaphylaxis (0 replies)
  80. Anaphylactic-Shock: Omeprazole/pantoprazole: anaphylaxis: 2 case reports (0 replies)
  81. Anaphylactic-Shock: Cefazolin: anaphylaxis: case report (0 replies)
  82. Anaphylactic-Shock: Ibuprofen: anaphylaxis in an infant: case report (0 replies)
  83. Anaphylactic-Shock: Stat3 is required for il-21-induced secretion of ige from human naive b cells (0 replies)
  84. Anaphylactic-Shock: Cefazolin: anaphylaxis: case report. (0 replies)
  85. Anaphylactic-Shock: Ibuprofen: anaphylaxis in an infant: case report. (0 replies)
  86. Anaphylactic-Shock: Omeprazole/pantoprazole: anaphylaxis: 2 case reports. (0 replies)
  87. Anaphylactic-Shock: Food-dependent exercise-induced anaphylaxis: possible impact of increased basophil histamine releasability in hyperosmolar conditions. (0 replies)
  88. Anaphylactic-Shock: Anaphylaxis to oral iron salts. desensitization protocol for tolerance induction. (0 replies)
  89. Anaphylactic-Shock: Is there a role for mast cells in psoriasis? (0 replies)
  90. Anaphylactic-Shock: Purification and characterisation of a panel of peanut allergens suitable for use in allergy diagnosis (0 replies)
  91. Anaphylactic-Shock: Food allergy: recent advances in pathophysiology and treatment. (0 replies)
  92. Anaphylactic-Shock: Neuromuscular blocking agents/opioid analgesics and various drugs: anaphylaxis during general anaesthesia: 23 case reports (0 replies)
  93. Anaphylactic-Shock: Vinorelbine: first report of anaphylaxis: case report (0 replies)
  94. Anaphylactic-Shock: Food allergy and food intolerance: diagnosis and treatment (0 replies)
  95. Anaphylactic-Shock: Neuromuscular blocking agents/opioid analgesics and various drugs: anaphylaxis during general anaesthesia: 23 case reports. (0 replies)
  96. Anaphylactic-Shock: Vinorelbine: first report of anaphylaxis: case report. (0 replies)
  97. Anaphylactic-Shock: Immunoglobulin e-mediated anaphylaxis to sesame. (0 replies)
  98. Anaphylactic-Shock: Bovine serum albumin contained in culture medium used in artificial insemination is an important anaphylaxis risk factor. (0 replies)
  99. Anaphylactic-Shock: S and m (usa) enterprise corp. issues alert on undeclared sulfites in grove grow notes brand dried bamboo fungus veiled lady (august 12) (0 replies)
  100. Anaphylactic-Shock: Hypersensitivity to intravenous ondansetron: a case report (0 replies)
  101. Anaphylactic-Shock: Chlorhexidine: anaphylaxis: case report (0 replies)
  102. Anaphylactic-Shock: Gadoterate meglumine: anaphylaxis in an elderly patient: case report (0 replies)
  103. Anaphylactic-Shock: Mecasermin: anaphylaxis: case report (0 replies)
  104. Anaphylactic-Shock: Changes in pulse oximetry after patent blue dye injection into the uterine cervix (0 replies)
  105. Anaphylactic-Shock: The role of il-10 in preventing food-induced anaphylaxis (0 replies)
  106. Anaphylactic-Shock: Chlorhexidine: anaphylaxis: case report. (0 replies)
  107. Anaphylactic-Shock: Gadoterate meglumine: anaphylaxis in an elderly patient: case report. (0 replies)
  108. Anaphylactic-Shock: Mecasermin: anaphylaxis: case report. (0 replies)
  109. Anaphylactic-Shock: Anaphylaxis caused by recurrent hydatid disease (0 replies)
  110. Anaphylactic-Shock: Anaphylactic shock in pregnancy: a case study and review of the literature. (0 replies)
  111. Anaphylactic-Shock: [pregnancy and hydatid cyst] (0 replies)
  112. Anaphylactic-Shock: The role of mast cells in eosinophilic esophagitis (0 replies)
  113. Anaphylactic-Shock: Anaphylaxis in the elderly (0 replies)
  114. Anaphylactic-Shock: Methotrexate: anaphylaxis in a child: case report. (0 replies)
  115. Anaphylactic-Shock: Ranitidine: fatal anaphylaxis following intravenous administration: case report. (0 replies)
  116. Anaphylactic-Shock: Toxoplasma gondii-derived heat shock protein 70 induces lethal anaphylactic reaction through activation of cytosolic phospholipase a and platelet-activating factor via toll-like receptor 4/myeloid differentiation factor 88. (0 replies)
  117. Anaphylactic-Shock: Icatibant acetate (0 replies)
  118. Anaphylactic-Shock: Anaphylaxis (0 replies)
  119. Anaphylactic-Shock: Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor. (0 replies)
  120. Anaphylactic-Shock: The use of vasopressors and inotropes in the emergency medical treatment of shock. (0 replies)
  121. Anaphylactic-Shock: Aprotinin: anaphylaxis following systemic administration in an elderly patient who had previously received aprotinin-containing fibrin sealant: case report (0 replies)
  122. Anaphylactic-Shock: Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy (0 replies)
  123. Anaphylactic-Shock: Oral sensitization with shrimp tropomyosin induces in mice allergen-specific ige, t cell response and systemic anaphylactic reactions (0 replies)
  124. Anaphylactic-Shock: An evaluation of the diamed assays for immunoglobulin a antibodies (anti-iga) and iga deficiency. (0 replies)
  125. Anaphylactic-Shock: Cortivazol: anaphylaxis to carmellose excipient: 2 case reports (0 replies)
  126. Anaphylactic-Shock: Sulphan blue: anaphylaxis: case report (0 replies)
  127. Anaphylactic-Shock: Cortivazol: anaphylaxis to carmellose excipient: 2 case reports. (0 replies)
  128. Anaphylactic-Shock: Sulphan blue: anaphylaxis: case report. (0 replies)
  129. Anaphylactic-Shock: Fatal injection of ranitidine: a case report (0 replies)
  130. Anaphylactic-Shock: Tumor necrosis factor-a develops late anaphylactic reaction through cytosolic phospholipase a 2 activation (0 replies)
  131. Anaphylactic-Shock: Enoxaparin sodium/heparin: anaphylaxis and decreased platelet count in patients with spontaneous prothrombotic disorder resembling hit?: 2 case reports (0 replies)
  132. Anaphylactic-Shock: Rocuronium bromide: anaphylaxis, treated with vasopressin: case report (0 replies)
  133. Anaphylactic-Shock: Enoxaparin sodium/heparin: anaphylaxis and decreased platelet count in patients with spontaneous prothrombotic disorder resembling hit?: 2 case reports. (0 replies)
  134. Anaphylactic-Shock: Rocuronium bromide: anaphylaxis, treated with vasopressin: case report. (0 replies)
  135. Anaphylactic-Shock: How to predict and prevent the immunogenicity of therapeutic proteins. (0 replies)
  136. Anaphylactic-Shock: One epinephrine dose may not suffice for children with multiple food allergies (0 replies)
  137. Anaphylactic-Shock: Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of myd88 adaptor molecule and interleukin-12/interferon-γ axis (0 replies)
  138. Anaphylactic-Shock: Man allergic to seafood dies after eating crab dish (0 replies)
  139. Anaphylactic-Shock: Man dies after eating seafood dish at ruby tuesday (0 replies)
  140. Anaphylactic-Shock: Anaphylactic shock caused by buffalo's mozzarella cheese (0 replies)
  141. Anaphylactic-Shock: Understanding the mechanisms of anaphylaxis. (0 replies)
  142. Anaphylactic-Shock: Epidemiology of anaphylaxis. (0 replies)
  143. Anaphylactic-Shock: Anaphylaxis in the emergency department: a paediatric perspective. (0 replies)
  144. Anaphylactic-Shock: Epidemiology of insect-venom anaphylaxis. (0 replies)
  145. Anaphylactic-Shock: Highlights in nonhymenoptera anaphylaxis. (0 replies)
  146. Anaphylactic-Shock: Anaphylactic shock caused by buffalo's mozzarella cheese. (0 replies)
  147. Anaphylactic-Shock: Anaphylaxis guideline update. (0 replies)
  148. Anaphylactic-Shock: Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. (0 replies)
  149. Anaphylactic-Shock: Development and validation of the self-administered food allergy quality of life questionnaire for adolescents. (0 replies)
  150. Anaphylactic-Shock: Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin: [presentation de cas: traitement d'un choc anaphylactique provoque par le rocuronium avec de la vasopressine]. (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.